Disclosed is a compound of formula (I), wherein the substituents are as defined in the specification. The compounds have selective affinity for 5-HT receptors and are useful in the treatment of central nervous system disease states such as psychoses, schizophrenia, manic depressions, neurological disorders, memory disorders, attention deficit disorder, Parkinson's disease, amyotrophic lateral scierosis, Alzheimer's disease, food uptake disorders and Huntington's disease.
Tetralin and indane derivatives and uses thereof